Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?

Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $50.39 and traded as high as $51.18. Goldman Sachs ActiveBeta Emerging Markets Equity ETF shares last traded at $51.01, with a volume of 190,516 shares traded.

Goldman Sachs ActiveBeta Emerging Markets Equity ETF Price Performance

The company’s 50 day moving average is $50.43 and its two-hundred day moving average is $48.14. The firm has a market cap of $1.74 billion, a P/E ratio of 13.33 and a beta of 0.71.

Hedge Funds Weigh In On Goldman Sachs ActiveBeta Emerging Markets Equity ETF

Large investors have recently added to or reduced their stakes in the company. Syntegra Private Wealth Group LLC grew its holdings in shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 1.7% during the 1st quarter. Syntegra Private Wealth Group LLC now owns 16,631 shares of the company’s stock worth $718,000 after purchasing an additional 281 shares in the last quarter. Transamerica Financial Advisors LLC raised its stake in shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 19.7% in the fourth quarter. Transamerica Financial Advisors LLC now owns 2,136 shares of the company’s stock valued at $89,000 after purchasing an additional 351 shares in the last quarter. Edge Financial Advisors LLC raised its stake in shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 2.2% in the fourth quarter. Edge Financial Advisors LLC now owns 19,242 shares of the company’s stock valued at $799,000 after purchasing an additional 422 shares in the last quarter. Orion Porfolio Solutions LLC lifted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 4.1% in the fourth quarter. Orion Porfolio Solutions LLC now owns 12,419 shares of the company’s stock worth $517,000 after purchasing an additional 484 shares during the period. Finally, Prostatis Group LLC lifted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 2.0% in the fourth quarter. Prostatis Group LLC now owns 32,805 shares of the company’s stock worth $1,365,000 after purchasing an additional 637 shares during the period.

About Goldman Sachs ActiveBeta Emerging Markets Equity ETF

The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of emerging market stocks comprising 4 sub-indexes: value, momentum, quality, and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight. GEM was launched on Sep 29, 2015 and is managed by Goldman Sachs.